RSS

Niemann-Pick Type A (NP-A)

Sanofi and subsidiary Genzyme have announced that the FDA has granted Breakthrough Therapy designation to olipudase alfa, an enzyme replacement therapy being investigated for the treatment of patients with non-neurological manifestations of ASMD... more

News